Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Liabilities (2019 - 2025)

Historic Total Liabilities for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $701.7 million.

  • Legend Biotech's Total Liabilities rose 1322.7% to $701.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $701.7 million, marking a year-over-year increase of 1322.7%. This contributed to the annual value of $629.6 million for FY2024, which is 541.99% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Total Liabilities is $701.7 million, which was up 1322.7% from $654.4 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Total Liabilities registered a high of $701.7 million during Q3 2025, and its lowest value of $408802.0 during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $597.2 million (2023), whereas its average is $546.8 million.
  • In the last 5 years, Legend Biotech's Total Liabilities crashed by 9985.61% in 2021 and then soared by 14714805.65% in 2022.
  • Quarter analysis of 5 years shows Legend Biotech's Total Liabilities stood at $353.5 million in 2021, then soared by 65.95% to $586.7 million in 2022, then grew by 1.8% to $597.2 million in 2023, then increased by 5.42% to $629.6 million in 2024, then rose by 11.45% to $701.7 million in 2025.
  • Its Total Liabilities stands at $701.7 million for Q3 2025, versus $654.4 million for Q2 2025 and $597.9 million for Q1 2025.